Clinical Trials

Carcinoma, Hepatocellular

NCT07392866 2026-02-09

A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

120 enrolled

Carcinoma, Hepatocellular

NCT07332533 2026-01-12

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

490 enrolled

HER2-positive Gastric Cancer

NCT07309419 2025-12-30

Cocktail-001

222 enrolled

Carcinoma, Hepatocellular

NCT05902533 2025-12-18

REDEL

33 enrolled

Anus Neoplasms

NCT07251062 2025-11-26

A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

737 enrolled

Esophageal Squamous Cell Carcinoma

NCT05980481 2025-09-29

A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer

201 enrolled

Stomach Neoplasms

NCT05141721 2025-05-16

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

700 enrolled

Colorectal Neoplasms

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

635 enrolled 9 charts

Colonic Neoplasms

NCT05065957 2025-04-30

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

Phase 2/3 Recruiting

180 enrolled

Biliary Tract Neoplasms

NCT02945566 2025-03-27

STAR-TREC

380 enrolled

Rectal Neoplasms

NCT01924819 2025-03-04

TOPGEAR

574 enrolled

Stomach Neoplasms

NCT06037980 2025-02-17

PURITY

Phase 2/3 Recruiting

300 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT03512756 2024-11-06

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

Phase 2/3 Terminated

130 enrolled 13 charts

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT01404156 2024-08-28

POWERRANGER

29 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT02746796 2024-05-03

Study of ONO-4538 in Gastric Cancer

680 enrolled

Stomach Neoplasms

NCT03607656 2023-12-18

CHANGE

270 enrolled

Stomach Neoplasms

NCT05976568 2023-08-04

A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

668 enrolled

Carcinoma, Hepatocellular

NCT04037241 2022-04-01

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Phase 2/3 Withdrawn

Malignant Tumor of Pancreas Metastatic to Liver

NCT01962246 2022-02-21

A-C

169 enrolled

Gastroesophageal Junction Adenocarcinoma

NCT05002686 2021-08-24

Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

60 enrolled

Stomach Neoplasms

NCT03093870 2021-08-03

TreeTopp

151 enrolled 18 charts

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms

NCT03158610 2021-05-03

Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer

Phase 2/3 Terminated

20 enrolled

Colorectal Neoplasms

NCT03959150 2021-04-30

Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

231 enrolled

Pancreatic Neoplasms

NCT00212615 2020-11-06

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

116 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT01516944 2020-02-13

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

749 enrolled

Stomach Neoplasms

NCT03873532 2020-02-13

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

298 enrolled

Biliary Tract Neoplasms

NCT00647530 2019-05-17

FOxTROT

1,053 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT02741856 2018-10-25

SCOPE2

584 enrolled

Esophageal Neoplasms

NCT01196260 2018-02-20

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

8,000 enrolled

Colorectal Neoplasms

NCT03428529 2018-02-09

INCAGI004

63 enrolled

Rectal Neoplasms

NCT00450203 2016-12-01

ST03

1,103 enrolled

Oesophagogastric Cancer

NCT02893540 2016-09-16

Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC

250 enrolled

Colorectal Neoplasms

NCT02529774 2015-08-20

Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer

432 enrolled

Resected Liver Metastases From Colorectal Cancer

NCT01065870 2014-01-29

Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)

64 enrolled

Pancreatic Neoplasms

NCT01097265 2013-08-12

Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

1,500 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

259 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01064999 2012-03-14

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

240 enrolled

Rectal Neoplasms

NCT00960284 2012-01-13

PACT-7

102 enrolled

Pancreatic Neoplasms

NCT00561522 2010-07-21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

290 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00294359 2007-08-22

The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer

333 enrolled